🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

26 recruiting trials

for Castration-Resistant Prostate Cancer (CRPC)

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma NCT03460977Phase 185 sites📍 Tucson📍 Tucson📍 Tucson Pfizer · Tests: Mevrometostat (PF-06821497), Enzalutamide, Itraconazole The COSMYC Trial (COmbined Suppression of MYC) NCT06922318Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: ZEN-3694, Testosterone cypionate, Enzalutamide, Luteinizing hormone-releasing hormone (LHRH) analogue Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging NCT06276465Phase 34 sites📍 Lorient📍 Mougins📍 Saint-Etienne UNICANCER · Tests: Darolutamide 300 mg, Stereotactic body radiation therapy, Androgen deprivation therapy A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites📍 Denver📍 Sarasota📍 Detroit IDEAYA Biosciences · Tests: IDE034 GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy NCT06636123Phase 11 site📍 Richmond Virginia Commonwealth University · Tests: Investigational Agent Administration A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors NCT05914116Phase 1, Phase 2107 sites📍 Tucson📍 Los Angeles📍 Los Angeles DualityBio Inc. · Tests: DB-1311, Lopinavir and Ritonavir Tablets, itraconazole, Enzalutamide, Abiraterone A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) NCT06842498Phase 223 sites📍 Goodyear📍 Scottsdale📍 Tucson Kyntra Bio · Tests: FG-3246 Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer NCT06705686Phase 11 site📍 Madison TechnoGenesys, Inc. · Tests: (R)-9bMS Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc NCT05534646Phase 23 sites📍 Duarte📍 Los Angeles📍 Salt Lake City Edwin Posadas, MD · Tests: AR Blockade, Carotuximab Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer NCT07007910Phase 11 site📍 Chengdu Haisco Pharmaceutical Group Co., Ltd. · Tests: HSK46575 A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC NCT07259213Phase 1, Phase 22 sites📍 Wollongong📍 Nedlands Radiopharm Theranostics, Ltd · Tests: 161Tb RAD402 Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT NCT06062745Phase 12 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: 18F-fluciclovine, PET/CT A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer NCT07258407Phase 1, Phase 27 sites📍 New Haven📍 Melbourne📍 Toronto T.O.A.D. Oncology SA · Tests: TD001 Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) NCT06549465Phase 29 sites📍 San Diego📍 Boston📍 St Louis Convergent Therapeutics · Tests: In-111 rosopatamab tetraxetan, 45 kBq/kg Ac-225 rosopatamab tetraxetan, 45 kBq/kg or equivalent fixed dose activity Ac-… Study of Oral MRT-2359 With Apalutamide in Prostate Cancer NCT07745361Phase 214 sites📍 Los Angeles📍 Newport Beach📍 Colorado Springs Monte Rosa Therapeutics, Inc · Tests: Oral MRT-2359, Apalutamide A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors NCT07540572Phase 111 sites📍 Plantation📍 East Brunswick📍 Lake Success IDEAYA Biosciences · Tests: IDE574, Fulvestrant injection Safety, Efficacy and Pharmacokinetics of TT00420 Tablets Combined With Novel Endocrine Therapy in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) NCT07871110Phase 216 sites📍 Fuzhou📍 Guangzhou📍 Guangzhou TransThera Sciences (Nanjing), Inc. · Tests: tinengotinib 10 mg QD plus darolutamide, tinengotinib 10 mg QD (2-week on / 1-week off) plus darolutamide, tinengotinib… Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer NCT06249750Phase 21 site📍 Hangzhou Pengyuan Liu · Tests: Immunotherapy, Targeted therapy, Hyperthermia A Study of DB-1310 in Advanced/Metastatic Solid Tumors NCT05785741Phase 1, Phase 224 sites📍 Sacramento📍 Santa Monica📍 Coral Gables DualityBio Inc. · Tests: DB-1310, Trastuzumab, Osimertinib, capecitabine 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors NCT07189871Phase 1, Phase 25 sites📍 Dothan📍 Grand Rapids📍 Omaha Radiopharm Theranostics, Ltd · Tests: 177Lu-BetaBart, BetaBart + unlabeled BetaBart Castrate Resistant Prostate Cancer Enhertu Therapy NCT06610825Phase 21 site📍 Washington D.C. Washington D.C. Veterans Affairs Medical Center · Tests: Enhertu Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 NCT06972628Phase 21 site📍 Houston Ebrahim S Delpassand · Tests: Administering Lutetium-177-PSMA-617 (PLUVICTO) Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer NCT06801236Phase 113 sites📍 La Jolla📍 Tampa📍 Baltimore Acerand Therapeutics (Hong Kong) Limited · Tests: ACE-232 tablets Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC NCT07813637Phase 11 site📍 Nashville Janux Therapeutics · Tests: JANX013, JANX007, JANX013, JANX007 Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial NCT07200830Phase 3138 sites📍 Anchorage📍 Bakersfield📍 Irvine Alliance for Clinical Trials in Oncology · Tests: Lutetium Lu 177 Vipivotide Tetraxetan, Biospecimen Collection, Patient Monitoring, Computed Tomography, Bone Scan The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC) NCT07038304Phase 22 sites📍 Groningen📍 Nijmegen University Medical Center Groningen · Tests: Metastasis directed radiotherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy